Rowlandmiller & Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.4M | Sell |
|
|||||
|
2025
Q2 | $8.45M | Sell |
|
|||||
|
2025
Q1 | $9.55M | Sell |
|
|||||
|
2024
Q4 | $8.4M | Buy |
|
|||||
|
2024
Q3 | $9.33M | Buy |
|
|||||
|
2024
Q2 | $8.01M | Sell |
|
|||||
|
2024
Q1 | $8.52M | Sell |
|
|||||
|
2023
Q4 | $7.29M | Sell |
|
|||||
|
2023
Q3 | $7.05M | Sell |
|
|||||
|
2023
Q2 | $6.41M | Sell |
|
|||||
|
2023
Q1 | $7.64M | Buy |
|
|||||
|
2022
Q4 | $7.73M | Sell |
|
|||||
|
2022
Q3 | $6.43M | Buy |
|
|||||
|
2022
Q2 | $7.24M | Sell |
|
|||||
|
2022
Q1 | $7.69M | Sell |
|
|||||
|
2021
Q4 | $6.48M | Buy |
|
|||||
|
2021
Q3 | $142K | Sell |
|
|||||
|
2021
Q2 | $4.75M | Buy |
|
|||||
|
2021
Q1 | $4.28M | Buy |
|
|||||
|
2020
Q4 | $155K | Sell |
|
|||||
|
2020
Q3 | $115K | Buy |
|
|||||
|
2020
Q2 | $142K | Sell |
|
|||||
|
2020
Q1 | $115K | Buy |
|
|||||
|
2019
Q4 | $124K | Buy |
|